The discovery of an overpayment raises serious questions about compliance requirements. Understand your organization’s reporting obligation and appropriate methods for determining overpayments.
Q: Starting January 1, 2021, CMS will be lowering reimbursement for high throughput novel coronavirus (COVID-19) diagnostic tests from $100 to $75. I understand that if certain requirements are met labs will be eligible to bill for a $25 add on code. How can we meet the requirements for the add on code?
CMS will reduce payments to laboratories that take longer than two days to complete high-throughput COVID-19 diagnostic tests effective January 1, 2021, according to an October 15 press release.
This week’s Medicare updates include new payment incentives for COVID-19 testing, the addition of 11 services to the telehealth list, updated data on the impact of COVID-19 on Medicare beneficiaries, and more!
CMS extended the timeline for organizations to repay payments received under its Accelerated and Advance Payment program, according to a fact sheet released October 8.
This week’s Medicare updates include the re-release of the October 2020 I/OCE quarterly data files, details on new COVID-19 reporting requirements for hospitals and critical access hospitals, and information on repayments for loans issued under the Accelerated and Advance Payment program at the beginning of the PHE.
